Gemcitabine: Treatment of breast cancer

[Annie pery]

Gemcitabine is a recommended drug for treating patients with advanced ovarian cancer, metastatic breast cancer, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer and pancreatic cancer. Nucleoside kinases metabolize gemcitabine to diphosphate (dFdCDP) and triphosphate nucleosides. Gemcitabine diphosphate inhibits ribonucleotide reductase, an enzyme responsible for catalyzing the reactions that generate deoxynucleoside triphosphates for DNA synthesis, resulting in reductions deoxynucleotide concentrations, including dCTP. Gemcitabine is supplied in 1 g and 200 mg single-dose vials for intravenous administration. One should store Gemcitabine at a controlled room temperature of 20° -25°C (68°-77°F), and that allows for excursions between 15° to 30°C or 59° to 86°F). 

Gemcitabine 1 gm injection price is economical, and one can purchase this medicine from a certified pharmaceutical supplier. For more information, please ring us on toll-free no. 18008891064.